wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33436535-46DCCF2E-3AB6-48D9-BC11-2A917A4DC0EA
Q33436535-46DCCF2E-3AB6-48D9-BC11-2A917A4DC0EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436535-46DCCF2E-3AB6-48D9-BC11-2A917A4DC0EA
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
P2860
Q33436535-46DCCF2E-3AB6-48D9-BC11-2A917A4DC0EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436535-46DCCF2E-3AB6-48D9-BC11-2A917A4DC0EA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
860c89e83c31c72447c2678af06b5600403ab79d
P2860
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.